Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
TXG

Market Cap: $8.71B

1I

10x Genomics, Inc.

TXG

NASDAQ (NASDAQ Global Select)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin70.03%

EBITDA Margin4.54%

EBIT Margin-1.34%

Pre-tax Margin-12.14%

Net Profit Margin-12.18%

Earnings Yield-0.84%

Valuation Multiples

Price / Book10.80

Price / Sales14.12

Price / Earnings-116.25

PEG0.25

Forward PEG33.82

EV / Sales13.43

EV / EBITDA295.82

EV / Operating Cash Flow65.19

EV / Free Cash Flow68.22

Price / Free Cash Flow71.71

Price / Operating Cash Flow70.15

Cash Flow & Capital

Free Cash Flow / Share$0.93

Operating Cash Flow / Share$0.98

Free Cash Flow Yield1.39%

Capex / Revenue0.92%

Capex / Operating Cash Flow4.45%

Capex / Depreciation0.13

Stock Compensation / Revenue16.01%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio5.69

Quick Ratio5.25

Cash Ratio4.24

Debt / Assets0.08

Debt / Capital0.09

Debt / Equity0.10

Long-Term Debt / Capital0.00

Debt / Market Cap0.14%

Net Debt / EBITDA-15.13

Solvency Ratio-0.19

Financial Leverage1.25

Efficiency & Working Capital

Asset Turnover0.60

Fixed Asset Turnover2.27

Inventory Turnover3.51

Receivables Turnover12.18

Payables Turnover8.93

Days Sales Outstanding29.96

Days Inventory Outstanding103.88

Days Payables Outstanding40.85

Operating Cycle133.83

Cash Conversion Cycle92.98

Working Capital Turnover1.11

Returns & Quality

Return on Equity-9.33%

Return on Assets-7.29%

Return on Invested Capital-9.57%

ROCE-9.70%

Return on Tangible Assets-7.81%

Operating Return on Assets-8.64%

Income Quality-1.69

Tax Burden1.00

Interest Burden9.07

Balance Sheet & Intrinsic Metrics

Enterprise Value$8.28B

Invested Capital$896.25M

Working Capital$556.16M

Tangible Asset Value$757.47M

Net Current Asset Value$470.15M

Graham Net-Net$3.17

Book Value / Share$6.35

Tangible Book Value / Share$5.83

Cash / Share$4.25

Financial Health Scores

Piotroski Score3

Altman Z-Score23.85

Revenue$616.91M

EBIT$-8.26M

Market Cap$8.43B

Working Capital$556.16M

Retained Earnings$-1.54B

Total Assets$1.03B

Total Liabilities$204.52M